Evidence map›Paper›PMID 42378452›Full record

ArticleCancer research communications2026

Tissue Context Shapes Distinct Premalignant Outcomes in an HPV16 E6/E7-Mutant Pik3ca Transgenic Mouse Model.

Marina Ayre, Gonzalo Fernandez-Ugazio, Anabel V DiGaudio, Omar Adrián Coso, J Silvio Gutkind, Ana Rosa Raimondi

Abstract read
In one paragraph

Article in Cancer research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marina AyreInstituto de Fisiología, Biología Molecular y Neurociencias (IFIBYNE-UBA-CONICET), Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina.ORCID 0009-0004-6284-7925
Gonzalo Fernandez-UgazioDepartamento de Patología, Hospital Zubizarreta, Buenos Aires, Argentina.ORCID 0009-0001-2394-7657
Anabel V DiGaudioInstituto de Fisiología, Biología Molecular y Neurociencias (IFIBYNE-UBA-CONICET), Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina.ORCID 0000-0002-7615-1329
Omar Adrián CosoInstituto de Fisiología, Biología Molecular y Neurociencias (IFIBYNE-UBA-CONICET), Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina.ORCID 0000-0002-8200-355X
J Silvio GutkindGleiberman Head and Neck Cancer Center, Moores Cancer Center, University of California San Diego Health, La Jolla, California.ORCID 0000-0002-5150-4482
Ana Rosa RaimondiInstituto de Fisiología, Biología Molecular y Neurociencias (IFIBYNE-UBA-CONICET), Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina.ORCID 0000-0002-8299-0989

Funding

UM CFAR SCCC Argentina Consortium for research and training in Virally Induced AIDS MalignanciesU54CA221208 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI COSO, OMAR ADRIAN, RAMOS, JUAN CARLOS · 2017 to 2022
$3.3M
Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) PICT 2017-0361Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) PIP 11220150100251CONational Cancer Institute (NCI) U54CA221208NCI NIH HHS U54 CA221208
6 · The paper itself

Abstract

High-risk human papillomavirus (HPV) infection, particularly HPV16, is a major etiologic factor associated with multiple human cancers, including anal, cervical, and oropharyngeal carcinomas. However, the mechanisms underlying tissue-specific responses to HPV oncogene expression remain poorly understood. In this study, we developed and characterized a double-inducible transgenic mouse model enabling spatially and temporally controlled expression of HPV16 E6/E7 oncoproteins in K14-positive epithelial progenitor cells of both the anal and oral mucosae. Within 2 months of induction, HPV16 E6/E7 expression elicited epithelial hyperplasia and dysplasia in both tissues but with distinct outcomes: low-grade squamous intraepithelial lesions in the anal canal and moderate to severe dysplasia in the tongue. Continuous oncogene expression was required for lesion maintenance, as doxycycline withdrawal reversed the proliferative phenotype, indicating a dynamic and reversible process. To assess whether activation of the PI3K pathway could cooperate with HPV oncogenes, we combined the E6/E7 model with a Pik3caH1047R knock-in mouse line. Constitutive PI3K activation alone induced mild dysplasia in both epithelia, whereas its combination with E6/E7 enhanced dysplastic severity in the tongue but not in the anal mucosa. No progression to invasive carcinoma was observed within 6 months. These findings demonstrate that identical oncogenic signals-HPV16 E6/E7 expression and PI3K activation-produce distinct premalignant outcomes depending on epithelial context. This work highlights the critical role of local microenvironmental factors in HPV-driven carcinogenesis and provides a platform to identify tissue-specific therapeutic vulnerabilities in HPV-associated cancers. SIGNIFICANCE: This work presents a double-inducible mouse model showing that HPV16 E6/E7 and PI3K activation drives distinct dysplastic outcomes in anal and oral epithelia. The study highlights how tissue context and microenvironment critically shape HPV oncogene effects, offering an important tool for uncovering mechanisms and therapeutic targets in HPV-related cancers.

Indexed as

Class I Phosphatidylinositol 3-KinasesOncogene Proteins, ViralPapillomavirus E7 ProteinsPapillomavirus InfectionsPrecancerous ConditionsRepressor ProteinsAnal CanalAnimalsAnus NeoplasmsDisease Models, AnimalFemaleHuman papillomavirus 16HumansMiceMice, TransgenicMouth MucosaClass I Phosphatidylinositol 3-KinasesE6 protein, Human papillomavirus type 16oncogene protein E7, Human papillomavirus type 16Oncogene Proteins, ViralPapillomavirus E7 ProteinsRepressor Proteins

Identifiers

PMID42378452
PMCPMC13389264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.